March 4, 2008 - By using a dual-source technique on a single computed tomography (CT) system, a research team at the Medical University of South Carolina’s (MUSC) Heart & Vascular Center was able to make a comprehensive diagnosis of heart disease, according to a report published in the current issue Circulation.
The team, led by Balazs Ruzsics, M.D., Ph.D.; Eric Powers, M.D., medical director of MUSC Heart and Vascular Center; and U. Joseph Schoepf, M.D., director of CT Research and Development, explored how CT scans can now detect blocked arteries and narrowing of the blood vessels in the heart in addition to poor blood flow in the heart muscle.
The single-scan technique would also provide considerable cost savings, as well as greater convenience and reduced radiation exposure for patients. For their approach, the MUSC physicians used a Dual-Source CT scanner. The MUSC scanner was the first unit worldwide that was enabled to acquire images of the heart with the ‘dual-energy’ technique. While the CT scan "dissects" the heart into thin layers, enabling doctors to detect diseased vessels and valves, it could not detect blood flow. The MUSC researchers added two X-ray spectrums, each emitting varying degrees of energy like a series of X-rays, to gain a static image of the coronary arteries and the heart muscle. This dual-energy technique of the CT scan enables mapping the blood distribution within the heart muscle and pinpointing areas with decreased blood supply.
All this is accomplished with a single CT scan within one short breath-hold of approximately 15 seconds or less. In addition to diagnosing the heart, the CT scan also permits doctors to check for other diseases that may be lurking in the lungs or chest wall.
MUSC, like most cardiovascular centers, had traditionally relied on several imaging modalities, such as cardiac catheterization, nuclear medicine or magnetic resonance (MR) scanners.
"This technique could be the long coveted ‘one-stop-shop’ test that allows us to look at the heart vessels, heart function and heart blood flow with a single CT scan and within a single breath-hold," said Dr. Schoepf, the lead investigator of the study.
Based on their initial observations, Heart & Vascular Center physicians have launched an intensive research project aimed at systemically comparing the new scanning technique to conventional methods for detecting decreased blood supply in the heart muscle.

For more information: www.musc.edu or www.muschealth.com


Related Content

News | PET-CT

June 19, 2025 — Building on a collaboration that spans more than three decades, GE HealthCare has renewed its research ...

Time June 19, 2025
arrow
News | Cardiac Imaging

April 30, 2025 – Viz.ai, the leader in AI-powered disease detection and intelligent care coordination, has launched Viz ...

Time May 02, 2025
arrow
News | Lung Imaging

April, 15, 2025 — Optellum has entered an agreement with Bristol Myers Squibb to leverage AI in early diagnosis and ...

Time April 17, 2025
arrow
News | Pediatric Imaging

April 10, 2025 — Cincinnati Children’s and GE HealthCare will form a strategic research program focused on driving ...

Time April 10, 2025
arrow
News | SPECT Imaging

Feb. 5, 2025 — Serac Healthcare Ltd., a clinical radiopharmaceutical company developing an innovative molecular imaging ...

Time February 05, 2025
arrow
News | Computed Tomography (CT)

Dec. 3, 2024 — During RSNA '24, GE HealthCare announced the 510(k) submission to the U.S. Food and Drug Administration ...

Time December 18, 2024
arrow
News | SPECT Imaging

Dec. 2, 2024 — GE HealthCare has agreed to acquire full ownership of Nihon Medi-Physics Co., Ltd (NMP), by purchasing ...

Time December 05, 2024
arrow
News | Computed Tomography (CT)

At the annual AHRA (American Healthcare Radiology Administrators) conference in Orlando, Florida, Bayer announced an ...

Time August 09, 2024
arrow
Videos | Radiology Business

Find actionable insights to achieve sustainability and savings in radiology in this newest of ITN’s “One on One” video ...

Time July 30, 2024
arrow
News | Radiopharmaceuticals and Tracers

July 24, 2024 — Telix Pharmaceuticals Limited announced that the United States (U.S.) Food and Drug Administration (FDA) ...

Time July 24, 2024
arrow
Subscribe Now